Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate for painless fiberoptic bronchoscopy
ChiCTR2600124266Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Ningbo University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine in bronchopulmonary diseases, sponsored by First Affiliated Hospital of Ningbo University. Primary endpoint: Oliceridine dose. Planned start May 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2600124266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124266.